Xanadu Bio

Xanadu Bio is a privately held, next generation nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that utilizes PACE platform technology. PACE technology is a next-generation polymeric nanoparticle that consists of three monomers that are fully biodegradable, and allows for efficient delivery of and protection from nuclease degradation for different types of nucleic acids, including mRNA. PACE is easily manufactured, cost effective, scalable and can be functionalized to allow both organ and cell specific delivery of its nucleic acid payload. PACE is formulated and optimized to allow safe delivery either systemically or intranasally. Leveraging PACE, Xanadu is initially focused on developing nasal vaccine boosters for the prevention and treatment of SARS CoV-2 infection and for other indications.